A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT03328273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03328273
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2021-09-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.